STRATA SKIN SCIENCES, INC. Additional Paid in Capital
STRATA SKIN SCIENCES, INC. had Additional Paid in Capital of $257.31 million as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2026-03-26
- 2025-12-31: Additional Paid in Capital $257.31M.
- 2025-09-30: Additional Paid in Capital $255.77M.
- 2025-06-30: Additional Paid in Capital $253.37M.
- 2025-03-31: Additional Paid in Capital $253.24M.
| Period end | Additional Paid in Capital | Additional Paid in Capital as first filed |
|---|---|---|
| 2025-12-31 | $257.31M 10-K · filed 2026-03-26 | |
| 2025-09-30 | $255.77M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $253.37M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $253.24M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $253.11M 10-K · filed 2026-03-26 | |
| 2024-09-30 | $252.99M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $251.02M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $250.82M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $250.74M 10-K · filed 2025-03-28 | $250.71M 10-K · filed 2024-03-28 |
| 2023-09-30 | $250.42M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $250.09M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $249.35M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $249.02M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $248.83M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $248.38M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $247.93M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $247.06M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $246.98M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $246.07M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $245.49M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $244.83M 10-K · filed 2022-03-21 | |
| 2020-09-30 | $244.42M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $244.02M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $243.61M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $243.18M 10-K · filed 2021-03-25 | |
| 2019-09-30 | $242.87M 10-Q · filed 2019-11-18 | |
| 2019-06-30 | $242.61M 10-Q · filed 2019-11-14 | |
| 2019-03-31 | $242.31M 10-Q · filed 2019-11-08 | |
| 2018-12-31 | $241.99M 10-K · filed 2020-03-17 | |
| 2018-09-30 | $239.04M 10-K · filed 2019-10-30 | $266.85M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $238.67M 10-K · filed 2019-10-30 | $266.49M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $223.85M 10-K · filed 2019-10-30 | $251.66M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $223.83M 10-K · filed 2019-10-30 | $251.64M 10-K · filed 2018-04-02 |
| 2017-09-30 | $223.78M 10-K · filed 2019-10-30 | $251.59M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $197.81M 10-K · filed 2019-10-30 | $225.62M 10-Q · filed 2017-08-11 |
| 2017-03-31 | $197.58M 10-K · filed 2019-10-30 | $225.40M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $197.47M 10-K · filed 2019-10-30 | $225.28M 10-K · filed 2017-03-13 |
| 2016-09-30 | $225.55M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $225.44M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $223.70M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $223.31M 10-K · filed 2017-03-13 |